FDA approves 1st COVID-19 test cleared with CLIA waiver

The FDA cleared for commercial distribution a diagnostic panel that tests for multiple respiratory viral and bacterial infections on Feb. 3.

Advertisement

The BioFire Spotfire Respiratory Panel is the first COVID-19 test cleared with a CLIA waiver, according to an AHA news release shared with Becker’s. Any lab with at least a CLIA certificate of waiver can use it.

The panel diagnoses infections in respiratory specimens from patients with suspected respiratory infections including COVID-19, according to the news release.

It consists of a closed system disposable pouch with all necessary reagents for sample preparation, reverse transcription, PCR and detection from a single swab specimen

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Lab

Advertisement

Comments are closed.